Study Meets Primary Endpoint with 25 Percent LDL Reduction in Very High-Risk Patient Population
- Details
- Category: Genzyme
![Genzyme Corp. Genzyme Corp.](http://www.worldpharmanews.com/images/stories/logo/genzyme.gif)
Lower doses of antigen may suffice to generate a protective immune response against A(H1N1)
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Abbott Announces Positive Three-Year Data on Its Fully Bioabsorbable Stent Technology
- Details
- Category: Abbott
![Abbott Abbott](http://www.worldpharmanews.com/images/stories/logo/abbott.gif)
BRILINTA Demonstrated Greater Efficacy Over Clopidogrel in the Most Urgent Clinical Setting
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](http://www.worldpharmanews.com/images/stories/logo/astrazeneca_b.gif)
Sanofi-aventis and Regeneron expand strategic Antibody Collaboration
- Details
- Category: Sanofi
![sanofi-aventis sanofi-aventis](http://www.worldpharmanews.com/images/stories/logo/sanofi-avenits.gif)
Novartis launches Prevacid® 24 HR over-the-counter
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Nycomed reports continued satisfactory performance in the third quarter 2009
- Details
- Category: Nycomed
![Nycomed Nycomed](http://www.worldpharmanews.com/images/stories/logo/nycomed.gif)
More Pharma News ...
- Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
- FDA approves GSK's pandemic H1N1 vaccine
- Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement
- WHO Grants Prequalification for Global Use to GSK's 10-Valent Synflorix⢠Vaccine
- Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
- Novartis to expand its human vaccines presence in China
- New Merck Begins Operations